GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor. The sensor is designed to be implanted under the skin and can transmit continuous glucose values to an external unit or smartphone for over a year, significantly improving the quality of life for patients with diabetes.

The sensor is composed of a sensing unit which detects glucose and provides a glucose-dependent optical signal using a biosensor, and a detection unit which reads the optical signals and transmits the data to the external unit.

GluSense is part of the Rainbow Medical innovation house.